Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Montelukast adjunctive therapy for nephrotic syndrome in children
IRCT20130518013366N13Phase 3Completed
- Sponsor
- Arak University of Medical Sciences
- Start
- Sep 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, single-blind trial of montelukast in nephrosis (2 arms), sponsored by Arak University of Medical Sciences. Primary endpoints: Albumin level, Urinary tract infection and 1 more. Started Sep 2019; status: completed.
02
Drugs
montelukast
03
Conditions
nephrosis
Beyond the preview
Go deeper on IRCT20130518013366N13.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20130518013366N13.